These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2343599)

  • 1. Simple ways to promote cost containment.
    Bunz DM; Frighetto L; Gupta S; Jewesson PJ
    DICP; 1990 May; 24(5):546. PubMed ID: 2343599
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of an antibiotic cost containment measure.
    Jung B; Andrews JD
    Can J Hosp Pharm; 1990 Jun; 43(3):116-22. PubMed ID: 10105649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clindamycin formulary restriction lowers costs, antimicrobial resistance.
    Am J Health Syst Pharm; 1998 Aug; 55(15):1552. PubMed ID: 9706176
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacy initiatives to reduce clindamycin use.
    Greene SA; Record KE; Rapp RP; Amerson AB; Bell RM; Piecoro JJ
    Am J Hosp Pharm; 1986 May; 43(5):1210-3. PubMed ID: 3717177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidisciplinary cost-containment program promoting oral metronidazole for treatment of antibiotic-associated colitis.
    Briceland LL; Quintiliani R; Nightingale CH
    Am J Hosp Pharm; 1988 Jan; 45(1):122-5. PubMed ID: 3348224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metronidazole cost containment: a two-stage intervention.
    Bunz D; Gupta S; Jewesson P
    Hosp Formul; 1990 Nov; 25(11):1167-9, 1177. PubMed ID: 10107821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cost containment tool for antibiotics.
    Judd C; Moist L; Rose C; Gopaul D
    Dimens Health Serv; 1989 Nov; 66(8):25-6. PubMed ID: 2606294
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost reductions for IV antibiotics in a 150-bed hospital.
    Baughman TL
    QRB Qual Rev Bull; 1984 Feb; 10(2):41-4. PubMed ID: 6424077
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost containment measures in hospital pharmacy: a bibliography.
    Treleaven S; Einarson TR
    Can J Hosp Pharm; 1990 Feb; 43(1):17-25. PubMed ID: 10106452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost.
    Climo MW; Israel DS; Wong ES; Williams D; Coudron P; Markowitz SM
    Ann Intern Med; 1998 Jun; 128(12 Pt 1):989-95. PubMed ID: 9625685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of DRGs and cost-containment: assessment by hospital pharmacy directors.
    McGhan WF; Larson LN; Raisch DW
    Hosp Formul; 1986 Aug; 21(8):870-1, 874-6. PubMed ID: 10311626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital cost containment and the pharmacist.
    Zellmer WA
    Am J Hosp Pharm; 1979 Jan; 36(1):31. PubMed ID: 758782
    [No Abstract]   [Full Text] [Related]  

  • 13. The hospital pharmacy: cost containment offers real challenges.
    Warren RW
    Tex Hosp; 1981 Jul; 37(2):6. PubMed ID: 10252579
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacy rounds: a cost containment tool.
    Poremba A; Stevenson JG
    Top Hosp Pharm Manage; 1988 Aug; 8(2):22-9. PubMed ID: 10314292
    [No Abstract]   [Full Text] [Related]  

  • 15. Two approaches to cost containment in hospital pharmacy.
    Strand LM; Morley PC
    Am J Hosp Pharm; 1985 Apr; 42(4):852-6. PubMed ID: 4014239
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of a target drug monitoring program on the usage of clindamycin.
    Gin AS; Lipinski LA; Honcharik N
    Can J Hosp Pharm; 1994 Apr; 47(2):53-8. PubMed ID: 10134127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost analysis of mixing clindamycin and aminoglycosides.
    Abel SR; Olson SM
    Am J Hosp Pharm; 1987 Jun; 44(6):1385-7. PubMed ID: 3618617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clindamycin and metronidazole as independent risk factors for nosocomial acquisition of multidrug-resistant Pseudomonas aeruginosa.
    Cipriano Souza R; Vicente AC; Vieira VV; Marques SG; Soares Md; Moura MC; Koifman RJ
    J Hosp Infect; 2008 Aug; 69(4):402-3. PubMed ID: 18511147
    [No Abstract]   [Full Text] [Related]  

  • 19. How we practice effective cost containment and maintain services.
    Newberg DF
    Pharm Times; 1985 Jul; 51(7):80-1. PubMed ID: 10272031
    [No Abstract]   [Full Text] [Related]  

  • 20. Managerial strategies for cost containment pressures.
    Ezaki LS
    Curr Concepts Hosp Pharm Manage; 1984; 6(4):10-3. PubMed ID: 10268512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.